The dose used in this study is lower than the 2.4 milligram dose often prescribed specifically for weight loss in the general population
Originally developed for diabetes management, these drugs, popularized under brand names such as Ozempic, Wegovy, Mounjaro, and Zepbound, are redefining how we think about obesity, metabolic health, and even chronic disease prevention
The Court will later consider a Motion to Dismiss
S., Song, M., Staller, K., & Chan, A
Metabolic Improvements Beyond the scale, people take this medication for the secondary health benefits
All references to liability are allegations that remain unproven in court